PFIZER INC Goodwill, Acquired During Period
PFIZER INC (PFE) reported Goodwill, Acquired During Period of $2.16 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2026-02-26
- PFIZER INC goodwill, acquired during period for the quarter ending 2024-12-31 was $361.00M.
- PFIZER INC goodwill, acquired during period for the quarter ending 2024-09-29 was -$16.00M.
- PFIZER INC goodwill, acquired during period for the quarter ending 2024-06-30 was -$847.00M.
- PFIZER INC goodwill, acquired during period for the quarter ending 2024-03-31 was $1.52B.
- PFIZER INC goodwill, acquired during period for fiscal 2025 was $2.16B, a 111.64% increase from fiscal 2024.
- PFIZER INC goodwill, acquired during period for fiscal 2024 was $1.02B, a 93.66% decline from fiscal 2023.
- PFIZER INC goodwill, acquired during period for fiscal 2023 was $16.12B, a 452.52% increase from fiscal 2022.
- PFIZER INC goodwill, acquired during period for fiscal 2022 was $2.92B.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.16B 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $361.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $345.00M derived: sum of 2 quarters · filed 2026-02-26 | -$502.00M derived: sum of 3 quarters · filed 2026-02-26 | $1.02B 10-K · filed 2026-02-26 |
| 2024-09-29 | -$16.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$863.00M derived: sum of 2 quarters · filed 2024-11-04 | $661.00M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | -$847.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $677.00M 10-Q · filed 2024-08-05 | ||
| 2024-03-31 | $1.52B 10-Q · filed 2024-05-08 | |||
| 2023-12-31 | $16.12B 10-K · filed 2025-02-27 | |||
| 2022-12-31 | $1.89B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $1.88B derived: sum of 2 quarters · filed 2024-02-22 | $1.89B derived: sum of 3 quarters · filed 2024-02-22 | $2.92B 10-K · filed 2024-02-22 |
| 2022-10-02 | -$4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $6.00M derived: sum of 2 quarters · filed 2022-11-09 | $1.03B 10-Q · filed 2022-11-09 | |
| 2022-07-03 | $10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $1.03B 10-Q · filed 2022-08-10 | ||
| 2022-04-03 | $1.02B 10-Q · filed 2022-05-11 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-02-23 | |||
| 2020-12-31 | $727.00M 10-K · filed 2022-02-24 | |||
| 2019-12-31 | $33.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $5.41B 10-K · filed 2021-02-25 | ||
| 2019-09-29 | $5.38B 10-Q · filed 2019-11-07 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $507.00M derived: sum of 2 quarters · filed 2019-02-28 | $593.00M derived: sum of 3 quarters · filed 2019-02-28 | $664.00M 10-K · filed 2019-02-28 |
| 2017-10-01 | $507.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $593.00M derived: sum of 2 quarters · filed 2017-11-09 | $664.00M 10-Q · filed 2017-11-09 | -$382.00M derived: sum of 4 quarters · filed 2018-02-22 |
| 2017-07-02 | $86.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $157.00M 10-Q · filed 2017-08-10 | -$889.00M derived: sum of 3 quarters · filed 2018-02-22 | $4.70B derived: sum of 4 quarters · filed 2018-02-22 |
| 2017-04-02 | $71.00M 10-Q · filed 2017-05-11 | -$975.00M derived: sum of 2 quarters · filed 2018-02-22 | $4.61B derived: sum of 3 quarters · filed 2018-02-22 | |
| 2016-12-31 | -$1.05B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $4.54B derived: sum of 2 quarters · filed 2018-02-22 | $6.37B 10-K · filed 2018-02-22 | |
| 2016-10-02 | $5.59B derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $7.42B 10-Q · filed 2016-11-10 | ||
| 2016-07-03 | $1.83B 10-Q · filed 2016-08-11 | |||
| 2015-12-31 | $7.32B 10-K · filed 2017-02-23 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $125.00M derived: sum of 2 quarters · filed 2015-02-27 | $125.00M derived: sum of 3 quarters · filed 2015-02-27 | $125.00M 10-K · filed 2015-02-27 |
| 2014-09-28 | $125.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $125.00M derived: sum of 2 quarters · filed 2014-11-06 | $125.00M 10-Q · filed 2014-11-06 | |
| 2014-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $0.00 10-Q · filed 2014-08-07 | ||
| 2014-03-30 | $0.00 10-Q · filed 2014-05-08 | |||
| 2012-12-31 | $208.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $223.00M derived: sum of 2 quarters · filed 2014-02-28 | $244.00M derived: sum of 3 quarters · filed 2014-02-28 | $605.00M 10-K · filed 2014-02-28 |
| 2012-09-30 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $36.00M derived: sum of 2 quarters · filed 2012-11-09 | $397.00M 10-Q · filed 2012-11-09 | $377.00M derived: sum of 4 quarters · filed 2013-02-28 |
| 2012-07-01 | $21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $382.00M 10-Q · filed 2012-08-09 | $362.00M derived: sum of 3 quarters · filed 2013-02-28 | $396.00M derived: sum of 4 quarters · filed 2013-02-28 |
| 2012-04-01 | $361.00M 10-Q · filed 2012-05-10 | $341.00M derived: sum of 2 quarters · filed 2013-02-28 | $375.00M derived: sum of 3 quarters · filed 2013-02-28 | $386.00M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-12-31 | -$20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $14.00M derived: sum of 2 quarters · filed 2013-02-28 | $25.00M derived: sum of 3 quarters · filed 2013-02-28 | $805.00M 10-K · filed 2013-02-28 |
| 2011-10-02 | $34.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $45.00M derived: sum of 2 quarters · filed 2011-11-10 | $825.00M 10-Q · filed 2011-11-10 | $933.00M derived: sum of 4 quarters · filed 2012-02-28 |
| 2011-07-03 | $11.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-11 | $791.00M 10-Q · filed 2011-08-11 | $899.00M derived: sum of 3 quarters · filed 2012-02-28 | $1.19B derived: sum of 4 quarters · filed 2012-02-28 |
| 2011-04-03 | $780.00M 10-Q · filed 2011-05-12 | $888.00M derived: sum of 2 quarters · filed 2012-02-28 | $1.18B derived: sum of 3 quarters · filed 2012-02-28 | |
| 2010-12-31 | $108.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $402.00M derived: sum of 2 quarters · filed 2012-02-28 | $2.25B 10-K · filed 2012-02-28 | |
| 2010-10-03 | $294.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-12 | $2.15B 10-Q · filed 2010-11-12 | ||
| 2010-07-04 | $1.85B 10-Q · filed 2010-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |